APRI Related FDA

Mar 18, 2013 11:18 AM Apricus Biosciences (APRI) Refocuses Strategy on Vitaros, Femprox; Updates on Outlook

Oct 1, 2012 06:47 AM Apricus Biosciences (APRI) to File MycoVa NDS in Canada

Sep 13, 2012 06:49 AM Apricus Bio (APRI), Takeda Enter Marketing Agreement for Vitaros in the U.K.

Jun 14, 2012 09:38 AM Apricus Bio (APRI) Files Response with Swissmedic Related to Vitaros MAA; May Trigger Pre-Decision

May 22, 2012 10:15 AM Apricus Biosciences (APRI) Granted Request for MycoVa Type C Regulatory Guidance from FDA

Mar 22, 2012 07:10 AM Apricus Biosciences (APRI) Gets Paatent Allowance for Dodecy1-2 by EPO

Feb 15, 2012 12:41 PM Apricus Bio (APRI) Pops on Vitaros Marketing News

Feb 15, 2012 12:38 PM Apricus Biosciences (APRI) Unit Signs Vitaros Marketing Agreement for Germany

Jan 27, 2012 08:03 AM Apricus (APRI), PediatRx Enter Binding Agreement for Granisol Co-Promotion

Jan 17, 2012 10:04 AM Apricus Biosciences (APRI) Gets Israeli Patent NoA for PE Treatment Cream

Jan 10, 2012 09:53 AM Apricus Bio (APRI) Signs MycoVa Marketing Agreement w/ Elis Pharma in Middle East, Gulf Countries

Jan 9, 2012 12:35 PM Apricus (APRI) Pops Following Vitaros Distribution Agreement; Up ~4-5%

Jan 9, 2012 12:30 PM Apricus (APRI) Grants Abbott Labs Ltd. Exclusive Vitaros Distribution Agreement in Canada

Jan 3, 2012 09:01 AM Apricus Bio (APRI), Stellar Pharma Sign MycoVa License Agreement in Canada

Oct 19, 2011 09:51 AM Apricus Biosciences (APRI) Receives Notice of Allowance from Korean Patent Office for Topical Cream to Treat Premature Ejaculation

Oct 3, 2011 11:04 AM Apricus (APRI) Gains Korean Patent Approval for Nail Fungus Treatment MycoVa

Aug 31, 2011 09:52 AM Apricus Biosciences (APRI) Unit Receives FDA Clearance for Diphenhydramine-D

Aug 23, 2011 10:21 AM Apricus Biosciences (APRI) Receives FDA Clearance for Second NexACT OTC Anti-Itch Drug

Aug 18, 2011 09:12 AM Apricus Biosciences (APRI) Receives FDA Approval to Produce its Tolnaftate-D Over the Counter Drug

Jun 27, 2011 10:19 AM Apricus (APRI) Revisits MycoVa Strategy Following Recent Phase III Data

Feb 17, 2011 09:26 AM Apricus (APRI), FDA in Discussions Regarding PrevOnco SPA Phase III Protocol

Jan 4, 2011 10:16 AM Apricus Biosciences (APRI) Enters Agreement to Bring ED Drug Vitaros to Part of the Middle East

Dec 23, 2010 09:35 AM Apricus Biosciences (APRI) Sees Continued Upside On Licensing Deal